These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 34804980)
1. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma. Zhang Y; Shao J; Li S; Liu Y; Zheng M Front Oncol; 2021; 11():775250. PubMed ID: 34804980 [TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. Hou W; Bonkovsky HL World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777 [TBL] [Abstract][Full Text] [Related]
3. Non-coding RNAs targeting NF-κB pathways in aquatic animals: A review. Zhao T; Zou Y; Yan H; Chang Y; Zhan Y Front Immunol; 2023; 14():1091607. PubMed ID: 36825023 [TBL] [Abstract][Full Text] [Related]
4. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Wang M; Yu F; Chen X; Li P; Wang K Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000 [TBL] [Abstract][Full Text] [Related]
5. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance. Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells. Huan L; Bao C; Chen D; Li Y; Lian J; Ding J; Huang S; Liang L; He X Cancer Sci; 2016 Mar; 107(3):258-66. PubMed ID: 26708147 [TBL] [Abstract][Full Text] [Related]
7. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma. Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101 [TBL] [Abstract][Full Text] [Related]
9. Non-coding RNA in drug resistance of hepatocellular carcinoma. Ding B; Lou W; Xu L; Fan W Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380 [TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis reveals role of the LINC01093/miR-96-5p/ZFAND5/NF-κB signaling axis in hepatocellular carcinoma. Zheng Y; Yu K; Huang C; Liu L; Zhao H; Huo M; Zhang J Exp Ther Med; 2019 Nov; 18(5):3853-3860. PubMed ID: 31641376 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling. Yu X; Tang W; Yang Y; Tang L; Dai R; Pu B; Feng C; Xia J Chem Biol Interact; 2018 Apr; 285():48-58. PubMed ID: 29481769 [TBL] [Abstract][Full Text] [Related]
12. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases. Gupta SC; Awasthee N; Rai V; Chava S; Gunda V; Challagundla KB Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188316. PubMed ID: 31639408 [TBL] [Abstract][Full Text] [Related]
14. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches. Jesenko T; Brezar SK; Cemazar M; Biasin A; Tierno D; Scaggiante B; Grassi M; Grassi C; Dapas B; Truong NH; Abrami M; Zanconati F; Bonazza D; Rizzolio F; Parisi S; Pastorin G; Grassi G Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111734 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. Wang D; Chen F; Zeng T; Tang Q; Chen B; Chen L; Dong Y; Li X Genes Dis; 2021 Mar; 8(2):157-167. PubMed ID: 33997162 [TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Wong CM; Tsang FH; Ng IO Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776 [TBL] [Abstract][Full Text] [Related]
18. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma. Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X Front Oncol; 2021; 11():696705. PubMed ID: 34367979 [TBL] [Abstract][Full Text] [Related]
19. Understanding the lncRNA/miRNA-NFκB regulatory network in diabetes mellitus: From function to clinical translation. Hoorzad P; Mousavinasab F; Tofigh P; Kalahroud EM; Aghaei-Zarch SM; Salehi A; Fattahi M; Le BN Diabetes Res Clin Pract; 2023 Aug; 202():110804. PubMed ID: 37369279 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. Wang H; Liang L; Dong Q; Huan L; He J; Li B; Yang C; Jin H; Wei L; Yu C; Zhao F; Li J; Yao M; Qin W; Qin L; He X Theranostics; 2018; 8(10):2814-2829. PubMed ID: 29774077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]